ID
33255
Description
Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains informations about the subjects eligibility. It should be filled out at each treatment period. Screening Visit: 28 days prior to first dosing. Treatment Period: The day before dosing, until 48h after dosing. Follow-Up: 14-21 days after last dose
Keywords
Versions (3)
- 12/3/18 12/3/18 -
- 12/18/18 12/18/18 -
- 1/9/19 1/9/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 3, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Effect of Lamictal on Resting Motor Threshold
Eligibility Review on Admission
- StudyEvent: ODM
Description
Eligibility Review on Admission
Alias
- UMLS CUI-1
- C0013893
- UMLS CUI-2
- C0030673
Description
If No, please give the reason below
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1512693
Description
Inclusion/Exclusion Criteria Comment
Data type
text
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1512693
Description
Sponsor contacted about Eligibility
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0332158
- UMLS CUI [1,2]
- C2347796
- UMLS CUI [1,3]
- C0013893
Description
Sponsor contacted about Eligibility Comment
Data type
text
Alias
- UMLS CUI [1,1]
- C0332158
- UMLS CUI [1,2]
- C2347796
- UMLS CUI [1,3]
- C0013893
Description
Proceed Dosage
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C0549178
Description
Proceed Dosage Comment
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C0549178
- UMLS CUI [1,3]
- C0947611
Description
Eligibility Review
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0013893
Description
Informed Consent
Alias
- UMLS CUI-1
- C0021430
Description
Informed Consent Obtained
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Description
Informed Consent Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0011008
Description
Conclusion
Alias
- UMLS CUI-1
- C1707478
Similar models
Eligibility Review on Admission
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0030673 (UMLS CUI-2)
C1512693 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
C2347796 (UMLS CUI [1,2])
C0013893 (UMLS CUI [1,3])
C2347796 (UMLS CUI [1,2])
C0013893 (UMLS CUI [1,3])
C0549178 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
C0013893 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1552089 (UMLS CUI [1,2])
No comments